Optarket en es it fr

Optarket Brand names, Optarket Analogs

Optarket Brand Names Mixture

  • No information avaliable

Optarket Chemical_Formula


Optarket RX_link

No information avaliable

Optarket fda sheet

Optarket msds (material safety sheet)

Optarket Synthesis Reference

No information avaliable

Optarket Molecular Weight

309.469 g/mol

Optarket Melting Point

< 25 oC

Optarket H2O Solubility

Soluble as HCl salt

Optarket State


Optarket LogP


Optarket Dosage Forms

Tablets (oral, 1 mg)

Optarket Indication

Used for the symptomatic treatment of parkinsonism.

Optarket Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Optarket Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Optarket side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Optarket Patient Information

Optarket Organisms Affected

Humans and other mammals